KBC Group
BLFS icon

KBC Group’s BioLife Solutions BLFS Stock Holding History

KBC Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,779
Closed -$25K – 1865
2023
Q3 		$25K Sell
1,779
-796
-31% -$12.5K ﹤0.01% 1849
2023
Q2 		$57K Hold
2,575
– – ﹤0.01% 1335
2023
Q1 		$56K Hold
2,575
– – ﹤0.01% 1354
2022
Q4 		$47K Hold
2,575
– – ﹤0.01% 1403
2022
Q3 		$59K Hold
2,575
– – ﹤0.01% 1352
2022
Q2 		$36K Buy
+2,575
New +$37.8K ﹤0.01% 1476
2021
Q4 		– Sell
-1,100
Closed -$47K – 1291
2021
Q3 		$47K Sell
1,100
-1,100
-50% -$53K ﹤0.01% 1242
2021
Q2 		$98K Hold
2,200
– – ﹤0.01% 1230
2021
Q1 		$80K Hold
2,200
– – ﹤0.01% 1257
2020
Q4 		$483K Hold
2,200
– – ﹤0.01% 1211
2020
Q3 		$64K Hold
2,200
– – ﹤0.01% 1199
2020
Q2 		$36K Buy
2,200
+1,100
+100% +$15.2K ﹤0.01% 1252
2020
Q1 		$10K Hold
1,100
– – ﹤0.01% 1268
2019
Q4 		$18K Sell
1,100
-1,480
-57% -$24.1K ﹤0.01% 1457
2019
Q3 		$43K Buy
2,580
+1,480
+135% +$27.8K ﹤0.01% 1391
2019
Q2 		$20K Hold
1,100
– – ﹤0.01% 1410
2019
Q1 		$20K Hold
1,100
– – ﹤0.01% 1372
2018
Q4 		$13K Buy
+1,100
New +$13.1K ﹤0.01% 1285

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group's BLFS Position: Q4 2023 in Review

KBC Group sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 1,779 shares — an estimated $25K sold.

KBC Group first reported a position in BLFS in Q4 2018 and held it in 18 quarters. The position peaked at $483K in Q4 2020. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • KBC Group reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • KBC Group sold 1,779 BioLife Solutions shares in Q4 2023, an estimated $25K.
  • KBC Group first reported a position in BioLife Solutions in Q4 2018 and held it in 18 quarters.
  • KBC Group's BioLife Solutions position peaked at $483K in Q4 2020.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.